Analysis and consideration on quality management characteristics of cell therapy product manufacturingYAN Ruo-xi1121-1129
Research on the pathways of high-quality innovation configuration for traditional Chinese medicine enterprises driven by digital technologyZHANG Yi-wen, MU Chun-lan, SHI Bing-xiao1130-1138
Exploratory investigation on the dynamic management of reference listed drugs for chemical generic drugsYANG Dong-sheng, FENG Yu-fei, LIU Nian, LIU Qian, ZHANG Guang-chao, NIU Jian-zhao, MA Ling-yun1139-1147
The European Patent Office's considerations on supplemental experimental data in sufficiency of disclosure examination of second medical use patentsHONG Meng-shi, OUYANG Xue-yu, WANG Fang-fei1154-1161
Research progress on the prediction process of neoantigensDAI Yi-fei, XIE Yu-jia, ZHANG Dong, WEI Xue-jing, REN Feng, CHEN Ai-ping1162-1169
Determination of biological activity of Insulin Icodec using homogeneous time-resolved fluorescence methodWANG Lü-yin, GAO Jing, LI He-yang, ZHANG Xiao-ming, LÜ Ping, LI Jing, LIANG Cheng-gang1170-1177
Preparation of alpha-1 antitrypsin and comparative analysis on two bioactivity measurement methodsFU Yan-li, GUO Yu-ting, KONG Tao, MA Ya-ru, LIANG Ling-yu, CHEN Yong1178-1184
Research on the degradation characteristics of polymers in implants and their impact on drug release behaviorLU Shu-yu, YIN Jie, DI Bin, YIN Li-hui1185-1198
Cancer-related ischemic stroke:mechanisms,biomarkers and advances in therapeutic strategiesWANG Yu-xin, XU Zhi-ru1199-1204